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Abstract
Purpose l-Theanine is the major free amino acid present in tea (Camellia sinensis L.). The effects of several tea constituents 
on male reproduction have been investigated, but l-theanine has been overlooked. Sertoli cells (SCs) are essential for the 
physical and nutritional support of germ cells. In this study, we aimed to investigate the ability of l-theanine to modulate 
important mechanisms of human SCs (hSCs) metabolism, mitochondrial function and oxidative profile, which are essential 
to prevent or counteract spermatogenesis disruption in several health conditions.
Methods We evaluated the effect of a dose of l-theanine attained by tea intake (5 μM) or a pharmacological dose (50 μM) 
on the metabolism (proton nuclear magnetic resonance and Western blot), mitochondrial functionality (protein expression of 
mitochondrial complexes and JC1 ratio) and oxidative profile (carbonyl levels, nitration and lipid peroxidation) of cultured 
hSCs.
Results Exposure of hSCs to 50 µM of l-theanine increased cell proliferation and glucose consumption. In response to this 
metabolic adaptation, there was an increase in mitochondrial membrane potential, which may compromise the prooxidant–
antioxidant balance. Still, no alterations were observed regarding the oxidative damages.
Conclusions A pharmacological dose of l-theanine (50 µM) prompts an increase in hSCs proliferation and a higher glucose 
metabolization to sustain the pool of Krebs cycle intermediates, which are crucial for cellular bioenergetics and biosynthesis. 
This study suggests an interplay between glycolysis and glutaminolysis in the regulation of hSCs metabolism.
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Introduction
Tea (Camellia sinensis L.) consumption has been associ-
ated with a wide variety of health benefits, thus encour-
aging many people to include it in their daily alimentary 
routine. Although tea composition is highly variable 
according to the type (white, green, oolong or black) and 
geographical origin, the most bioactive tea compounds 
include methylxanthines, phenolic compounds and amino 
acids. l-theanine (l-γ-glutamylethylamide) is a nonpro-
teinogenic amino acid almost exclusively found in this 
botanical species. l-theanine is usually associated with 
tea unique taste and relaxation properties. For that reason, 
it has gained popularity and become a common ingredient 
in functional beverages and food supplements.
Human reproduction is highly reliant on the success of 
sperm production in males. This complex process known 
as spermatogenesis is mainly sustained by Sertoli cells 
(SCs), which are the somatic cells present in the semi-
niferous tubules of the testes. These cells constitute the 
blood–testis-barrier (BTB), which is crucial for the physi-
cal support and protection of developing germ cells. They 
are also responsible for the production of several growth 
factors and nutrients, essential for germ cell survival and 
differentiation into spermatozoa [1]. The normal function 
of SCs metabolic processes is crucial for the preservation 
of male reproductive potential. These cells produce high 
amounts of lactate, which is then used as an energy source 
by the developing germ cells. The main substrate used 
by SCs to produce lactate is glucose, but they can also 
metabolize amino acids such as glutamine.
Several pathological conditions, such as diabetes mel-
litus and obesity, may trigger severe alterations in SCs 
metabolism, thus disturbing spermatogenesis and compro-
mising male fertility. In fact, the increasing incidence of 
those diseases around the world has been accompanied 
by a decrease in male reproductive health. This scenario 
highlighted the need to find new modulators of SCs metab-
olism to prevent the negative effects of those diseases on 
male reproduction. Studies from our team demonstrated 
that tea and some of its constituents [e.g., caffeine and 
epigallocatechin gallate (EGCG)] can modulate SC func-
tion in vitro [2–4] and improve male reproductive poten-
tial in vivo [5]. However, to our knowledge, there are no 
studies reporting the effects of l-theanine on SC function. 
l-theanine has demonstrated a preventive role against oxi-
dative stress in other cell types, such as hepatocytes [6] or 
neurons [7, 8]. One of the major concerns regarding SCs 
functions is that alterations in their metabolism can com-
promise the prooxidant–antioxidant homeostasis due to 
excessive production of reactive oxygen species (ROS). In 
this study, we aimed to investigate the ability of l-theanine 
to modulate important mechanisms of hSCs metabolism, 
mitochondrial function and oxidative profile, which are 
essential to prevent or counteract spermatogenesis disrup-
tion in several health conditions.
Materials and methods
Chemicals
The following chemicals were used—fetal bovine serum 
(FBS; S0615): Biochrom (Leonorenstr, Berlin, Germany); 
insulin–transferrin–selenium (ITS; 41400045): Gibco™ by 
Life Technologies (Carlsbad, California, USA); l-theanine 
(ab141187; CAS number 3081-61-6) and extracellular  O2 
consumption assay (ab197243): Abcam (Cambridge, UK); 
Tris base (MB01601) NZYTech (Lisbon, Portugal); M-PER 
Mammalian Protein Extraction Reagent (78501) and LDH 
Enzymatic Assay Kit (88954): Thermo Scientific (Waltham, 
MA, USA); JC1 (T3168): Molecular Probes (Eugene, OR, 
USA); All other chemicals: Sigma-Aldrich (St. Louis, MO, 
USA) unless specifically stated.
Cell primary cultures and experimental groups
The processing of human testicular tissue was performed at 
Centre for Reproductive Genetics Professor Alberto Barros 
(Porto, Portugal) according to local, national, and European 
ethical committees’ guidelines and the Declaration of Hel-
sinki. Six testicular biopsies were obtained from six differ-
ent patients with conserved spermatogenesis, after informed 
written consent. hSCs were obtained from the cells left in 
tissue culture plates after each patient’s treatment. Cells 
from each individual were plated separately in six cell + cul-
ture flasks (Sarstedt, Nümbrecht, Germany) and incubated 
at 33–34 °C, in a controlled atmosphere of 5%  CO2. The 
purity of hSCs culture was assessed by the immunoperoxi-
dase technique. Briefly, cells were incubated with primary 
polyclonal antibody and processed by the labeled streptavi-
din–biotin method using an ExtrAvidin Peroxidase Staining 
Kit (Sigma-Aldrich). Besides, specific protein markers, the 
anti-Mullerian hormone and vimentin, were also used to 
assess the purity of hSCs cultures [9]. After 96 h, cultures 
were examined by phase contrast microscopy and only hSCs 
with other cell contaminants below 5% were used.
Cells were left to grow until reach 90–95% confluence 
and cells from each flask were divided into three culture 
plates (Bioportugal, Porto, Portugal), making a total of 18 
plates. After reaching 90–95% confluence, the culture media 
of the culture plates were replaced by serum-free media 
(DMEM:F12) supplemented with ITS medium (10 µg/mL 
insulin–5.5 µg/mL transferrin–0.0067 µg/mL sodium sel-
enite). Three experimental groups were defined: a control 
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group (without l-theanine) and two groups supplemented 
either with 5 or 50 µM of l-theanine. Previous studies 
reported that the ingestion of 25–100 mg of l-theanine 
(either as tea or capsules) corresponded to a concentration 
of 5–25 µM in human plasma [10]. However, the beneficial 
health effects of l-theanine are mostly ascribed to higher 
doses of 200 mg, which correspond to a bioavailability of 
50 µM. Thus, we decided to use 5 and 50 µM in this study. 
Besides, this will also allow the comparison with previ-
ously studied tea components, EGCG and caffeine, using 
this in vitro model [2, 3]. After 24 h of treatment with 0 
(no l-theanine), 5 or 50 µM of l-theanine, cells and the 
respective culture media were collected. This time point was 
defined based on the fact that in serum, the concentration of 
l-theanine begins to drop slowly within 24 h [10]. Trypan 
blue exclusion test was performed to guarantee cellular 
integrity after the 24 h treatment, which averaged 85–90%.
Sulforhodamine B assay
A sulforhodamine B (SRB) colorimetric assay was per-
formed as previously described [3], to evaluate hSCs’ pro-
liferative responses to the 24 h exposure to 0, 5 or 50 µM of 
l-theanine. A blank was made with Tris base (pH 10) and 
the absorbance was read at 492 nm. Absorbance readings of 
SRB-stained cells give a direct measure of cell numbers. To 
obtain concentration–response curves, we defined the cell 
growth of the control group as 100% and calculated the cell 
growth of treated groups relative to control.
MTT reduction
To evaluate hSCs’ metabolic viability after expo-
sure to l-theanine, we measured the reduction of MTT 
(3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bro-
mide) tetrazolium to produce a purple formazan product. 
In brief, hSCs were cultured in a 96-well culture plate with 
DMEM:F12 supplemented with 10% FBS. After reaching 
90–95% confluence, hSCs were exposed to ITS medium sup-
plemented with 0, 5 or 50 µM of l-theanine for 24 h. Then, 
the medium was removed and replaced by 150 µL of freshly 
prepared ITS medium. MTT was firstly dissolved at 5 mg/
mL in warm PBS 1× and protected from light. 15 µL of 
MTT solution was added to each well to attain a final con-
centration of 0.5 mg/mL per well and cells were incubated 
during 3 h at 37 °C. At the end of incubation, the media were 
removed and formazan crystals were dissolved in 100 µL of 
DMSO by gentle shaking for 10 min at room temperature. 
A blank with DMSO was made for normalization. Absorb-
ance was recorded at 570 nm to quantify formazan forma-
tion (directly proportional to the number of viable cells) and 
also at 655 nm for reference. hSCs’ metabolic viability was 
expressed in fold variation to control.
LDH leakage and intracellular enzymatic activity
To evaluate the possible cytotoxicity of l-theanine to hSCs, we 
assessed lactate dehydrogenase (LDH) leakage (from damaged 
or destroyed cells) into the extracellular fluid and intracellular 
LDH activity levels after 24 h of exposure to the experimental 
doses. LDH levels were spectrophotometrically determined 
using the LDH Enzymatic Assay Kit according to the manu-
facturer’s instructions. For LDH leakage, 50 µL of extracel-
lular medium was mixed with 50 µL of LDH assay substrate 
and incubated at room temperature for 30 min. Then, 50 µL of 
LDH stop solution was added to stop the enzymatic activity 
and absorbance was measured at 490 nm and 630 nm using an 
Anthos 2010 microplate reader (Biochrom, Berlin, Germany). 
Results were normalized to the blank and expressed as fold 
variation to the control group. LDH intracellular activity was 
evaluated as previously described [2]. LDH enzymatic activi-
ties were calculated as units per milligram of protein using the 
molar extinction factor (ε) and final expressed as fold variation 
to the control group.
Autophagy
hSCs were grown in DMEM:F12 supplemented with 10% 
FBS, in 96-well plates until reaching 80–90% confluence. 
After treatment with 0, 5 or 50 µM of l-theanine for 24 h, 
the media were removed and cells were washed with PBS. 
Then, cells were incubated with 100 µL of propidium iodide 
(1 µg/mL in PBS) at room temperature for 2 min. Cells 
were washed again with PBS and incubated with 100 µL 
of dansylcadaverine (1 µg/mL in PBS) at 37 °C for 10 min. 
Afterward, cells were washed with PBS and incubated with 
100 µL of Hoechst (10 µg/mL in PBS) at room tempera-
ture for 10 min. During the incubation times, the 96-well 
plate was protected from light to avoid loss of fluorescence. 
After washing again, fresh PBS was added to each well and 
fluorescence was immediately analyzed using a Synergy HT 
Multi-Mode Microplate Reader (BioTek, Winooski, USA) 
pre-heated at 37 °C. Death cells stained with propidium 
iodide were detected at 530 ± 25/590 ± 35 nm (excitation/
emission), autophagic cells stained with dansylcadaverine 
were detected at 360 ± 40/528 ± 20 nm (excitation/emis-
sion) and cell nucleus stained with Hoechst were detected 
at 360 ± 40/460 ± 40 (excitation/emission). Results were nor-
malized to the number of cells and expressed as fold varia-
tion to the control group. A positive control of DMSO 10% 
was used for test validity.
Proton nuclear magnetic resonance (1H‑NMR) 
spectroscopy
Culture medium was collected before hSCs treatment (0 h) 
and after the 24 h of treatment with l-theanine, to allow 
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the analysis of metabolites production/consumption during 
that incubation period. 1H-NMR spectra of hSCs extracel-
lular culture media were acquired and quantified using the 
previously described conditions [5]. Sodium fumarate (final 
concentration of 1 mM) was used as an internal reference 
(6.50 ppm) to quantify the following metabolites present in 
hSCs extracellular media (multiplet, ppm): lactate (doublet, 
1.33); alanine (doublet, 1.45) and H1-α-glucose (doublet, 
5.22). Relative areas of 1H-NMR resonances and metabo-
lite concentrations were quantified as described [5]. Results 
are presented as metabolite consumption or production in 
pmol/cell.
Western blot
Total protein fraction from hSCs was isolated using M-PER 
Mammalian Protein Extraction Reagent according to the 
manufacturer’s instructions. Proteins were fractionated 
in 12% SDS-PAGE gels, then the separated proteins were 
transferred to previously activated polyvinylidene difluoride 
(PVDF) membranes and blocked for 90 min with a 5% non-
fat milk solution at room temperature. Afterward, the mem-
branes were incubated overnight (4 °C) with rabbit anti-
monocarboxylate transporter 4 (MCT4) (1:1000, sc-50329, 
Santa Cruz Biotechnology, Heidelberg, Germany), rabbit 
anti-lactate dehydrogenase (LDH) (1:10,000, ab52488, 
Abcam, Cambridge, UK) or mouse total OXPHOS cocktail 
(1:1000, ab110413, Abcam, Cambridge, UK) primary anti-
bodies. Mouse anti-β-actin (1:5000, MA5-15739, Thermo 
Scientific, Waltham, MA, USA) was used as the protein 
loading control. The immunoreactive proteins were detected 
separately and visualized after incubation (90 min at room 
temperature) with the respective secondary antibodies: goat 
anti-rabbit IgG-alkaline phosphatase (AP) (1:5000, A3687) 
or goat anti-mouse IgG-AP (1:5000, A3562). Membranes 
were reacted with ECF™ (GE, Healthcare, Buckingham-
shire, UK) and read with the Bio-Rad FX-Pro-plus (Bio-
Rad, Hemel Hempstead, UK). Densities from each band 
were obtained with BIO-PROFIL Bio-1D Software from 
Quantity One (Vilber Lourmat, Marne-la-Vallée, France) 
according to standard methods. The band density attained 
was divided by the corresponding β-actin band intensities 
and expressed as fold variation (induction/reduction) relative 
to the control group.
Mitochondrial membrane potential
The fluorescent probe 5-5′,6-6′-tetrachloro-1,1′,3,3′-
tetraethylbenzimidazol-carbocyanine iodide (JC1) was used 
to measure the mitochondrial membrane potential of hSCs 
after exposure to 0, 5 or 50 µM of l-theanine, as previously 
described [3]. The accumulation of the JC1 dye in mitochon-
dria depends upon the mitochondrial membrane potential. 
Fluorescence intensities were analyzed immediately using 
a Cytation™ 3 Cell Imaging Multi-Mode Reader (BioTek, 
Winooski, USA) pre-heated at 37 °C. Cells with functional 
mitochondria exhibited JC1 aggregates that were detected 
at 550/590 nm (excitation/emission), while cells with dys-
functional mitochondria mainly exhibited JC1 monomers 
detected at 485/535 nm (excitation/emission). The JC1 ratio 
aggregates/monomers were calculated for each condition as 
a measure of mitochondrial functionality. Results are pre-
sented as fold variation to the control group. A positive con-
trol with 10 µM of carbonyl cyanide-4-(trifluoromethoxy)
phenylhydrazone (FCCP) was used for assay validation.
Extracellular oxygen consumption assay
Oxygen consumption is one of the most informative and 
direct measures of mitochondrial function. We used the 
extracellular oxygen consumption assay kit (ab197243; 
Abcam, Cambridge, UK) as previously described [3], to 
measure the respiration of hSCs after 24 h exposure to 0, 5 or 
50 µM of l-theanine. A positive control of sodium bisulfite 
was used for assay validation. Fluorescence intensities were 
analyzed immediately using a Synergy HT Multi-Mode 
Microplate Reader (BioTek, Winooski, USA) pre-heated at 
37 °C. Extracellular oxygen consumption of hSCs was meas-
ured at 1.5 min intervals for 120 min at 380/650 nm (excita-
tion/emission). Cells’ respiration leads to oxygen depletion 
from the surrounding environment, resulting in the increase 
in fluorescence signal. Fluorescence intensities were normal-
ized to the blank and expressed as counts per second (CPS) 
versus time (min).
Analysis of carbonyl groups, nitration and lipid 
peroxidation
Carbonyl groups, nitration and lipid peroxidation are usu-
ally used as biomarkers for oxidation and can be evalu-
ated by measuring its resulting products, 2,4-dinitrophenyl 
(DNP), nitro-tyrosine and 4-hydroxynonenal (4-HNE), 
respectively. The content of these adducts in hSCs after 
exposure to l-theanine was evaluated by slot blot technique. 
The resulting PVDF membranes were incubated overnight 
(4 °C) with rabbit anti-DNP (D9656, Sigma-Aldrich, St. 
Louis, MO, USA), rabbit anti-nitro-tyrosine (#9691, Cell 
signaling Technology, Leiden, Netherlands) or goat anti-4-
HNE (AB5605, Merck Millipore Temecula, USA) primary 
antibodies (dilution 1:5000). The immunoreactive proteins 
were detected separately and visualized with goat anti-
rabbit IgG-AP (1:5000, A3687) or rabbit anti-goat IgG-AP 
(1:5000, A4187). Results were expressed as fold variation 
to the control group.
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Statistical analysis
Statistical significance was assessed by a two-tailed 
Mann–Whitney test for independent samples, using the 
GraphPad Prism 6 software (GraphPad Software, San 
Diego, CA, USA). All data are presented as mean ± SEM 
(N = 6). Differences with p < 0.05 were considered statisti-
cally significant.
Results
Pharmacological dose of l‑theanine induces 
an increase in hSCs proliferation while maintaining 
cellular metabolic viability
Our results showed a significant increase in hSCs prolifera-
tion after exposure to a pharmacological dose of 50 µM of 
l-theanine (191 ± 17%), not only relative to the control group 
(100 ± 8%; p = 0.002) but also to the group of hSCs exposed 
to 5 µM of l-theanine (121 ± 7%; p = 0.009) (Fig. 1A). None-
theless, hSC metabolic viability, as reflected by the MTT 
assay, was maintained when cultured with 5 or 50 µM of 
l-theanine (1.09 ± 0.14 and 1.02 ± 0.18-fold variation to con-
trol, respectively) in comparison to the non-exposed hSCs 
(Fig. 1B). In fact, the addition of 5 or 50 µM of l-theanine 
to the culture medium was not cytotoxic to hSCs, as dem-
onstrated by the LDH leakage assay (Fig. 1C). The group 
of hSCs exposed to 5 µM of l-theanine presented an LDH 
leakage of 1.23 ± 0.24-fold variation to the control, a similar 
value to those exposed to 50 µM of l-theanine (1.27 ± 0.17-
fold variation to control) and with no significant alterations 
relative to the control group (without l-theanine). Moreover, 
an autophagy assay was performed to evaluate if the selected 
doses of l-theanine could affect hSC autophagic process, but 
no differences were found among the experimental groups 
(Fig. 1D). The autophagy levels in the groups of hSCs 
exposed to 5 or 50 µM of l-theanine were 1.07 ± 0.06 and 
1.02 ± 0.06-fold variation to control, respectively.
Glucose consumption by hSCs was stimulated 
by exposure to the pharmacological dose 
of l‑theanine
Our results showed that non-exposed hSCs presented a glu-
cose consumption of 7.23 ± 3.85 pmol/cell. The addition of 
5 μM of l-theanine to the cell culture medium did not affect 
glucose consumption (8.74 ± 2.11 pmol/cell) in compari-
son to the control group. On the other hand, there was an 
increase (to 28.55 ± 7.24 pmol/cell) in glucose consumption 
of hSCs exposed to the pharmacological dose of l-theanine 
(50 μM), relative not only to the control group (p = 0.032) 
but also to the group of hSCs exposed to 5 μM of l-theanine 
(p = 0.016) (Fig. 2A).
Lactate production was maintained after exposure 
to l‑theanine
Our results demonstrated that LDH protein levels were simi-
lar in hSCs from the control group and those cultured with 
5 or 50 µM of l-theanine (1.07 ± 0.15 and 0.92 ± 0.11-fold 
variation to control, respectively) (Fig. 2B). Besides, LDH 
activity of hSCs exposed to 5 or 50 μM of l-theanine was 
0.74 ± 0.12 and 1.14 ± 0.30-fold variation to the control, 
Fig. 1  Effect of l-theanine (5 
and 50 µM) in human Sertoli 
cells (hSCs) survival. The figure 
shows pooled data of inde-
pendent experiments, indicat-
ing hSCs proliferation (A), 
metabolic viability (B), LDH 
cytotoxicity (C) and autophagy 
(D). Cell proliferation data are 
presented as percentage, where 
the control value was set at 
100%, while that of metabolic 
viability, LDH cytotoxicity 
and autophagy are presented 
as fold variation to the control. 
All results are expressed as 
mean ± SEM (n = 6 for each 
condition). Significantly differ-
ent results (p < 0.05) are indi-
cated as: a—relative to control; 
b—relative to 5 μM l-theanine
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respectively, with no significant differences to LDH activ-
ity in hSCs from the control group (Fig. 2C). Likewise, 
lactate production by hSCs was not altered by exposure 
to the selected doses of l-theanine (Fig. 2D). In fact, non-
exposed hSCs produced 12.75 ± 2.33 pmol/cell of lactate 
and hSCs exposed to 5 or 50 μM of l-theanine produced 
a similar amount (15.38 ± 1.51 and 12.91 ± 2.20 pmol/cell, 
respectively). Moreover, the protein levels of MCT4 in hSCs 
exposed to 5 or 50 µM of l-theanine were similar to those of 
the control group (1.09 ± 0.30 and 1.08 ± 0.37-fold variation 
to control, respectively). In addition, alanine production by 
hSCs was not altered by exposure to l-theanine (data not 
shown).
Mitochondrial membrane potential increased 
in hSCs exposed to the pharmacological dose 
of l‑theanine
The addition of 5 or 50 µM of l-theanine to hSCs cul-
ture medium did not induce significant alterations in the 
protein levels of mitochondrial complexes I–V (Table 1). 
Additionally, the established mitochondrial membrane 
potential of hSCs was evaluated by the JC1 ratio and our 
results showed an increase in hSCs cultured with 50 µM 
of l-theanine (2.02 ± 0.25-fold variation to the control) 
relative to the control group (p = 0.010). No significant dif-
ferences were found among hSCs from the control group 
and those exposed to 5 µM of l-theanine (1.60 ± 0.24-fold 
variation to the control) (Fig. 3A). Nevertheless, oxygen 
consumption was similar among the hSCs from the several 
experimental groups (Fig. 3B). 
Exposure to l‑theanine did not induce oxidative 
damage in hSCs
We have measured the levels of the end products resultant 
from protein oxidation or nitration, as well as lipid per-
oxidation on hSCs after exposure to 5 or 50 μM of l-thea-
nine. Our data showed that the addition of 5 or 50 μM of 
l-theanine to the culture medium of hSCs did not alter the 
levels of carbonyl groups, nitration or lipid peroxidation 
comparatively to the control group (Table 2).
Fig. 2  Effect of l-theanine (5 and 50 µM) in glucose metabolism of 
human Sertoli cells (hSCs). The figure shows pooled data of inde-
pendent experiments, indicating glucose consumption (A), LDH and 
MCT4 protein levels (B), LDH activity (C) and lactate production 
(D). B Also displays the representative blots (of one sample) of LDH 
and MCT4. While glucose consumption and lactate production are 
presented as pmol/cell, results from protein levels and LDH activity 
are presented as fold variation to the control. All results are expressed 
as mean ± SEM (n = 6 for each condition). Significantly different 
results (p < 0.05) are indicated as: a—relative to control; b—relative 
to 5 μM l-theanine
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Discussion
It was previously shown that l-theanine can have an impor-
tant role in the preservation of rat sperm viability (ex vivo) 
when combined with EGCG and caffeine [4], but the under-
lying molecular mechanisms are still unknown. As SCs’ 
function is essential for the support of spermatogenesis and 
male fertility, in the present study, we used an in vitro model 
of hSCs to unveil the effects of l-theanine in these somatic 
testicular cells.
l-Theanine is considered safe for humans as no toxic 
effects have been reported so far, though the regulation for 
its ingestion varies among countries. While in Japan l-thea-
nine use in dietary products has no dose restrictions, in the 
USA, the Food and Drug Administration (FDA) considers it 
to be generally recognized as safe (GRAS), but recommends 
a maximum daily consumption of 1200 mg. Nevertheless, 
as its effects on cultured hSCs are unknown, we evaluated 
the effect of two doses of theanine (5 μM—representing a 
quantity easily obtained through diet; and 50 μM—repre-
senting a pharmacological dose) in hSCs. Firstly, we evalu-
ated hSC proliferation, metabolic viability, autophagy and 
LDH release (Fig. 1) after 24 h of exposure. The incubation 
with the lowest dose of l-theanine (5 µM) did not prompt 
any alterations in the considered parameters, while exposure 
of hSCs to the pharmacological dose of l-theanine (50 µM) 
induced an increase in cell proliferation when compared to 
the control group. These results suggest that the selected 
doses are not toxic for hSCs. Besides, as each SC can only 
support a limited number of germ cells [11], a higher prolif-
eration may be important to increase spermatozoa produc-
tion and improve male reproductive potential. However, we 
must consider that in vivo the proliferation of adult SCs is 
limited, so data extrapolation should be made carefully. Still, 
this in vitro model of proliferating hSCs is a well-established 
and published model for toxicological studies [2, 12–14], 
retaining many specific characteristics of its derived tissue 
[15]. A recent study also reported the pro-proliferative action 
of l-theanine exposure (1–100 µM for 12 days) in cultured 
murine neuronal progenitor cells [16], thus corroborating 
our observations.
Generally, high proliferating cells require an increased 
uptake of nutrients. As hSCs can reprogram their metab-
olism to meet their needs, we evaluated the production/
consumption of key metabolic metabolites. One of the 
major roles of hSCs is to metabolize glucose to produce 
pyruvate and lactate, so these substrates can be used for 
energy production by developing germ cells. Hence, hSCs 
metabolism highly relies on glycolysis. Our results showed 
Table 1  Protein expression levels of mitochondrial complexes in 
human Sertoli cells from the control group and groups exposed to 5 
or 50 µM of l-theanine
Results are expressed as mean ± SEM (fold variation to the control), 
n = 6 for each condition
CI NADH dehydrogenase (ubiquinone) 1 beta subcomplex subunit 8 
(NDUFB8), CII Succinate dehydrogenase complex, subunit B, iron 
sulfur (SDHB), CIII ubiquinol-cytochrome c reductase core protein 
II (UQCRC2), CIV mitochondrially encoded cytochrome c oxidase I 




Control 5 µM of l-theanine 50 µM of l-theanine
CI 1.00 ± 0.18 1.07 ± 0.06 0.98 ± 0.15
CII 1.00 ± 0.14 1.13 ± 0.17 0.90 ± 0.12
CIII 1.00 ± 0.09 0.99 ± 0.14 0.85 ± 0.06
CIV 1.00 ± 0.11 1.02 ± 0.11 0.86 ± 0.09
CV 1.00 ± 0.08 1.20 ± 0.22 0.89 ± 0.08
Fig. 3  Effect of l-theanine (5 and 50  μM) in mitochondrial func-
tion of human Sertoli cells (hSCs). The figure shows pooled data of 
independent experiments, indicating mitochondrial membrane poten-
tial (JC1 ratio) (A) and extracellular  O2 consumption (B). Results 
are presented as fold variation to control. Results are expressed as 
mean ± SEM (n = 5 for each condition). Significantly different results 
(p < 0.05) are indicated as: a—relative to control; b—relative to 5 μM 
l-theanine; c—relative to 50 μM l-theanine. FCCP carbonyl cyanide-
4-(trifluoromethoxy)phenylhydrazone
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that the addition of a pharmacological dose of l-theanine 
(50 µM) to hSCs culture medium triggers a higher con-
sumption of glucose (Fig. 2A), which is the main substrate 
available in the culture media (18 mM). A higher glucose 
uptake suggests that more pyruvate is being produced 
through glycolysis. We could not detect pyruvate in the 
extracellular media, as analyzed by the 1H-NMR, which 
indicates that it is being used by the cells. Pyruvate is an 
important regulatory point of cell metabolism as it can fol-
low three different pathways: (1) it can be converted to lac-
tate by LDH; (2) it can produce alanine; or (3) it can enter 
the mitochondria to form acetyl-CoA and fuel the Krebs 
cycle [1]. Both LDH protein expression levels and activity 
were similar between the experimental groups, resulting in 
a normal production of lactate in hSCs exposed to l-thea-
nine. Moreover, the protein expression of MCT4, a spe-
cific monocarboxylate transporter that exports lactate and 
pyruvate to the extracellular medium, was also normal, 
showing that lactate and pyruvate production and export 
were not altered in the presence of l-theanine. Likewise, 
alanine production was similar between the experimen-
tal groups (data not shown). This led us to speculate that 
the higher pyruvate production resulting from the higher 
glucose uptake was used by the mitochondria to produce 
metabolic intermediates necessary for anabolic processes 
that support the higher cellular proliferation. The fact 
that we did not detect acetate or citrate in the extracel-
lular media (by the 1H-NMR analysis) supports that these 
metabolites are used to fuel the Krebs cycle, as they are 
exported to the extracellular compartment when they are 
not required for cellular processes. In fact, an increased 
mitochondrial membrane potential was observed in the 
group of hSCs exposed to the pharmacological dose of 
l-theanine (50 µM) (Fig. 3A), suggesting that l-theanine 
influences hSC mitochondrial function. NADH reduced 
coenzyme produced from glycolysis contains electrons 
that have a high transfer potential. These electrons are 
removed from NADH and passed to oxygen by the electron 
transport chain (ETC—mitochondrial complexes I–IV) in 
the mitochondrial inner membrane. So, the increased gly-
colytic rates of hSCs exposed to the pharmacological dose 
of l-theanine (50 µM) induced an increased mitochondrial 
membrane potential. However, the protein expression of 
mitochondrial complexes (OXPHOS) was not altered 
(Table 1), neither was oxygen consumption (Fig. 3B). Still, 
in response to the detected metabolic changes, mitochon-
drial alterations could lead to an imbalanced ROS produc-
tion and affect cellular proteins and lipids. However, our 
results show that hSCs oxidative profile was not altered 
by exposure to l-theanine (Table 2). This may be due to a 
normal mitochondrial function or the antioxidant proper-
ties attributed to this amino acid. In fact, previous studies 
demonstrated that l-theanine is able to increase cellular 
antioxidant capacity due to its structural similarity to glu-
tamic acid, as it is also a precursor of the main endogenous 
antioxidant glutathione [17].
Besides glycolysis, glutaminolysis is also a very impor-
tant process to maintain the high metabolic rates of hSCs. 
Glutamine can be incorporated by hSCs through glutamate 
receptors, being hydrolyzed to glutamate by the enzyme 
glutaminase (EC 3.5.1.2). Consequently, glutamate may 
be excreted, or it can be further metabolized to yield 
α-ketoglutarate, a reaction-specific substrate for the Krebs 
cycle. l-Theanine structure is very similar to that of glu-
tamine, thus being able to bind to glutamate receptors in 
cells, although with lower affinity (80-fold difference). It 
has been reported that in brain cells, l-theanine may exert 
an agonist or antagonist action on glutamate receptors in a 
dose- and receptor-dependent manner [18]. Glutamine is a 
core metabolite for tumor cell proliferation. So, the inhibi-
tion of glutamate receptors by l-theanine is under investi-
gation in many cancer studies, to find new ways to prevent 
tumor cells proliferation. In the present study, if an inhibi-
tion of glutamine uptake by hSCs was occurring, we would 
be able to measure these metabolites in the extracellular 
media by the 1H-NMR. As this was not the case and it was 
initially present in the extracellular media (3 mM), it was 
consumed by the hSCs. Moreover, as l-theanine is a precur-
sor of glutamate, at the pharmacological dose it seems to be 
an extra source of glutamate for hSCs, thus explaining why 
this group of cells proliferate more. Previous in vitro studies 
with other cells suggested that even if l-theanine cannot be 
metabolized through glutaminolysis, it is similarly incor-
porated into cell cytoplasm and can exert a glutamate-like 
effect [16]. A stimulation of glycolysis by glutamate was 
previously reported [19], as demonstrated in our study.
Table 2  Oxidative damage levels, evaluated by carbonyl groups, nitration and lipid peroxidation, of human Sertoli cells from the control group 
and groups exposed to 5 or 50 µM of l-theanine
Results are expressed as mean ± SEM (fold variation to the control), n = 6 for each condition
Oxidative damage levels Control 5 µM of l-theanine 50 µM of l-theanine
Carbonyl groups 1.00 ± 0.11 1.01 ± 0.12 1.05 ± 0.09
Nitration 1.00 ± 0.13 1.02 ± 0.14 1.05 ± 0.18
Lipid peroxidation 1.00 ± 0.11 0.92 ± 0.06 0.98 ± 0.14
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Conclusions
Our data indicate that exposure of hSCs to a pharmaco-
logical dose of l-theanine (50 µM) prompts an increase 
in cell proliferation and a higher glucose metabolization. 
This leads to an increased glycolytic rate to maintain the 
pools of Krebs cycle intermediates for ATP production and 
cellular components synthesis, to support the anabolic pro-
cesses needed for building new cells. Although the mecha-
nisms by which these metabolic alterations induce cell 
growth and proliferation remain poorly understood, the 
proliferative rates are correlated with substrate availability 
and cellular metabolism. Besides, a higher proliferation of 
hSCs may be important to maintain spermatogenesis and 
improve male reproductive potential. The glutamine-like 
effects of l-theanine reinforce the complementary action 
between glucose and glutaminolysis in hSC metabolic 
function. Overall, our results support that a pharmaceuti-
cal l-theanine supplementation may be used to prevent or 
counteract spermatogenesis disruptions caused by some 
health conditions.
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